findmyKOL

Peter Buttrick, MD

Basic profile

University of Colorado Anschutz Medical Campus

ORCIDNPI
RegionAurora, CO · WestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2023Online presenceNot yet checkedPaymentsNone reportedNIH funding2007–2026Why? →

Peter Buttrick is a Cardiology physician affiliated with University of Colorado Anschutz Medical Campus. OpenAlex indexes 180 publications with 7,002 citations (h-index 45).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
180publications

Distinct works indexed by OpenAlex, matched via ORCID.

7,002citations

Total citations across indexed works.

45h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7NIH grants · 2007–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

12605 E 16th Ave
Aurora, CO 800452545

Telephone

720-848-0000

Registry record last updated 3 Oct 2012.

View the NPPES registry record

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    77.7%
    Beta blocker21.7%
    Metoprolol Succinate47%Metoprolol Tartrate22%Carvedilol17%Labetalol Hcl13%
    Part D<11 patients
    Statin15.9%
    Atorvastatin Calcium53%Rosuvastatin Calcium32%Pravastatin Sodium15%
    Part D<11 patients

    + 9 more classes in this area

  • Blood & clotting

    18.1%
    Factor Xa inhibitor8.3%
    Eliquis61%Xarelto39%
    Part D<11 patients
    P2Y12 inhibitor6.1%
    Brilinta50%Clopidogrel50%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    4.2%
    SGLT2 inhibitor2.3%
    Jardiance100%
    Part D<11 patients
    Potassium supplement1.9%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

7 NIH research awards on record, funded 20072026 per NIH RePORTER. The latest:

32 more award records behind the reveal.Reveal →

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”